Fukoku Co., Ltd. Launches 'Phicello NK/T Series' Activated NK Cell Mass Culture Kit
Fukoku Co., Ltd. has launched the 'Phicello NK/T series,' a kit designed for the efficient culture and activation of NK cells. Utilizing a closed-system bag container, the kit reduces contamination risks and improves operational efficiency.
📋 Article Processing Timeline
- 📰 Published: May 20, 2026 at 01:16
- 🔍 Collected: May 19, 2026 at 17:01
- 🤖 AI Analyzed: May 20, 2026 at 07:24 (14h 22m after Collected)
## Overview
Fukoku Co., Ltd. (Headquarters: Ageo City, Saitama Prefecture) has launched the 'Phicello NK/T series,' a mass culture kit for activated NK cells.
This product is highly convenient, suppressing the proliferation of cells such as T cells and selectively activating and proliferating only NK cells from human peripheral blood-derived cells. 'Phicello' is a registered trademark of Fukoku Co., Ltd.
## Product Composition
- Phicello NK/T advance: Culture medium for initial culture (bottle, 500mL, Product No.: 830019)
- Phicello NK/T Supplement: Supplement for NK activation (10mL, Product No.: 834004)
- Phicello NK/T advance DIRECT: Culture medium for expansion culture (closed-system bag, 800mL, Product No.: 831006)
## Features
- Media-filled bags reduce contamination risks and improve operational efficiency.
- Selectively activates and proliferates NK cells (achieving an NK cell ratio of 91.3%).
- Eliminates the need for flask antibody coating, enabling efficient culture.
- Fukoku's proprietary closed-system bag container reduces contamination risks from foreign matter, bacteria, and viruses.
- Uses highly safe raw materials.
*Note: This product is for research use only.
## Future Initiatives
Through product development, expansion of the lineup, and sales based on efficacy verification and evidence, Fukoku aims to contribute to the regenerative medicine and genetic fields, thereby improving people's lives.
Fukoku Co., Ltd. (Headquarters: Ageo City, Saitama Prefecture) has launched the 'Phicello NK/T series,' a mass culture kit for activated NK cells.
This product is highly convenient, suppressing the proliferation of cells such as T cells and selectively activating and proliferating only NK cells from human peripheral blood-derived cells. 'Phicello' is a registered trademark of Fukoku Co., Ltd.
## Product Composition
- Phicello NK/T advance: Culture medium for initial culture (bottle, 500mL, Product No.: 830019)
- Phicello NK/T Supplement: Supplement for NK activation (10mL, Product No.: 834004)
- Phicello NK/T advance DIRECT: Culture medium for expansion culture (closed-system bag, 800mL, Product No.: 831006)
## Features
- Media-filled bags reduce contamination risks and improve operational efficiency.
- Selectively activates and proliferates NK cells (achieving an NK cell ratio of 91.3%).
- Eliminates the need for flask antibody coating, enabling efficient culture.
- Fukoku's proprietary closed-system bag container reduces contamination risks from foreign matter, bacteria, and viruses.
- Uses highly safe raw materials.
*Note: This product is for research use only.
## Future Initiatives
Through product development, expansion of the lineup, and sales based on efficacy verification and evidence, Fukoku aims to contribute to the regenerative medicine and genetic fields, thereby improving people's lives.
FAQ
Where can I purchase the Phicello NK/T series?
Please refer to the official website of Fukoku Co., Ltd. or their bio-industry product information page.
Which cells can be cultured with this kit?
It is primarily intended for culturing NK cells derived from human peripheral blood.
Is the product approved for clinical trials?
This product is for research use only.